CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
89.01%
Total 13F principal
$294,542,079
Principal change
+$28,715,077
Total reported market value
$262,019,315
Number of holders
31
Value change
+$23,698,044
Number of buys
13
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q2 2019

As of 30 Jun 2019, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 31 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $294,542,079 in principal (par value) of the bond. The largest 10 bondholders included Antara Capital LP, Allianz Asset Management GmbH, D. E. Shaw & Co., Inc., Marble Ridge Capital LP, ADVENT CAPITAL MANAGEMENT /DE/, WESTWOOD HOLDINGS GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), SYMPHONY ASSET MANAGEMENT LLC, Graham Capital Management, L.P., and TENOR CAPITAL MANAGEMENT Co., L.P.. This page lists 31 institutional bondholders reporting positions for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.